603367 logo

Cisen Pharmaceutical Co., Ltd. Stock Price

SHSE:603367 Community·CN¥6.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603367 Share Price Performance

CN¥13.46
-1.43 (-9.60%)
CN¥13.46
-1.43 (-9.60%)
Price CN¥13.46

603367 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

1 Risk
1 Reward

Cisen Pharmaceutical Co., Ltd. Key Details

CN¥3.4b

Revenue

CN¥1.7b

Cost of Revenue

CN¥1.7b

Gross Profit

CN¥1.2b

Other Expenses

CN¥408.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.90
49.02%
12.10%
0.6%
View Full Analysis

About 603367

Founded
1970
Employees
3114
CEO
Zhenxin Du
WebsiteView website
www.cisen-pharma.com

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products. The company’s chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, anesthetic and analgesic drugs, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal drugs. It also offers Chinese medicine preparations; complete and incomplete nutritional formula food; specific nutritionally complete formula foods; nutritious food; health food; raw materials; and packaging products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Jining, the People's Republic of China.

Recent 603367 News & Updates

Recent updates

No updates